Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.69B P/E - EPS this Y -13.00% Ern Qtrly Grth -
Income -245.65M Forward P/E -11.65 EPS next Y -6.70% 50D Avg Chg 16.00%
Sales 5.85M PEG -1.36 EPS past 5Y - 200D Avg Chg 56.00%
Dividend N/A Price/Book 6.51 EPS next 5Y 9.00% 52W High Chg -1.00%
Recommedations 2.80 Quick Ratio 5.72 Shares Outstanding 67.05M 52W Low Chg 119.00%
Insider Own 2.19% ROA -26.82% Shares Float 61.16M Beta 0.67
Inst Own 96.71% ROE -56.85% Shares Shorted/Prior 2.88M/3.13M Price 40.19
Gross Margin - Profit Margin - Avg. Volume 1,723,853 Target Price 40.30
Oper. Margin -3,998.12% Earnings Date Nov 8 Volume 8,174,954 Change -0.25%
About Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington. As of August 11, 2023, Chinook Therapeutics, Inc. operates as a subsidiary of Novartis AG.

KDNY Chatroom

User Image RallyRaider Posted - 04/11/24

$KDNY $VERA will get FDA approval in IGAN, i believe its taken out after that. After i got out around 31, ill buy some shares today. Alwas follow the money.

User Image RallyRaider Posted - 03/14/24

$KDNY $VERA by the looks of it, VERA is next...

User Image fin_researcher Posted - 01/11/24

$KDNY In May 2023, Muddy Waters accused Chinook and AbbVie of manipulating trial results for lead product candidate, Atrasentan. On it, $KDNY fell 7%, losing $100M+ shareholder value. Investors may have reasons to suspect Chinook of unlawful biz practices, which consequently led to their losses: https://11thestate.com/cases/chinook-investor-case

User Image Stan_Vick Posted - 12/30/23

~ In May 2023, Muddy Waters accused # Chinook and AbbVie of manipulating trial results for lead product candidate. ~ $KDNY fell 7%, losing $100M+ shareholder value. ~ Investors may suspect $KDNY of unlawful biz practices, which led to their losses => https://11thestate.com/cases/chinook-investor-case

User Image Uncle_Sammy_Trades Posted - 11/30/23

$KDNY how is the chart here the same every day? This is a scam.

User Image stockilluminati Posted - 08/21/23

$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form 15-12G today, check out the details.

User Image Quantisnow Posted - 08/21/23

$KDNY 📜 SEC Form 15-12G filed by Chinook Therapeutics Inc. https://quantisnow.com/i/4921829?utm_source=stocktwits 45 seconds delayed.

User Image tickeron Posted - 08/20/23

Chinook Therapeutics to report earnings on August 21, 2023. Earnings per share (EPS) estimate: $-0.90 $KDNY https://srnk.us/go/4838684

User Image stockilluminati Posted - 08/17/23

$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form EFFECT today, check out the details.

User Image Quantisnow Posted - 08/17/23

$KDNY 📜 SEC Form EFFECT filed by Chinook Therapeutics Inc. https://quantisnow.com/i/4909081?utm_source=stocktwits 45 seconds delayed.

User Image MGCapManagement Posted - 08/15/23

$KDNY anyone know what happens to my call exp 8.18? How will they expire? Do I get paid? I wrote to chinook and they haven't responded.

User Image Twit_Rip Posted - 08/14/23

$KDNY i sold this for somewhere between 19-22$ i hate myself right now. I only had 5 shares kicking around. Ill make 200$ off this merger. :( … i dont know what i was thinking i always believed in this stock… some lucky people out there getting paid $$$

User Image tickeron Posted - 08/13/23

Chinook Therapeutics to report earnings on August 14, 2023. Earnings per share (EPS) estimate: $-0.85 $KDNY https://srnk.us/go/4829907

User Image Kewgardens Posted - 08/12/23

$KDNY Had some short $40 $KDNY calls called away right before the deal closed. So as of today, I am short about 1500 shares at ~$40.73 (strike plus premium). I know that my account will be debited $40 per share because of the $40 per cash offer. But what happens to the CVRs? Will a CVR security be issued? Will it trade on an exchange? I will be short that security and will be looking to close out my position. How do thinks proceed from here?

User Image Last10K Posted - 08/11/23

$KDNY just filed with the SEC a Ending Agreement, a Change in Assets, a Listing Status, a Security Holders Change, a Change in Control, a Event for Officers, a Bylaw Change and a Financial Exhibit https://last10k.com/sec-filings/KDNY/0001193125-23-210803.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=KDNY

User Image stockilluminati Posted - 08/11/23

$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form SC 13D today, check out the details.

User Image SkiesOfBlue Posted - 08/11/23

@BeaconABB Short term damage from capital raise to complete Ph3 activities. But they know owning a big winner for long term, with future partnerships or even potential buyout. I own $KDNY and got 6x gain from recent buyout by $NVS. Just my opinion and not financial advice. Do your own DD and place your bet GL

User Image stockilluminati Posted - 08/11/23

$KDNY https://www.stockilluminati.com/kdny/filings.php - Chinook Therapeutics, Inc. - Common Stock files form POSASR today, check out the details.

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form S-8 POS https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 08/11/23

$KDNY / Chinook Therapeutics files form POSASR https://fintel.io/sf/us/kdny?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
Wedbush Neutral Aug 8, 23
Wells Fargo Equal-Weight Aug 1, 23
HC Wainwright & Co. Neutral Jun 21, 23
Evercore ISI Group In-Line Jun 14, 23
Stifel Hold Jun 13, 23
SVB Leerink Market Perform Jun 13, 23
HC Wainwright & Co. Neutral Jun 13, 23
Cantor Fitzgerald Neutral Jun 12, 23
Guggenheim Neutral Jun 12, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
King Andrew James Chief Scientific Off.. Chief Scientific Officer Jul 29 Sell 39.03 1,168 45,587 19,157 08/01/23
Greenman William Mariner Director Director May 26 Sell 23.3 1,155 26,912 23,643 05/31/23
DOBMEIER ERIC President, CEO President, CEO Apr 24 Sell 21.92 25,000 548,000 301,138 04/26/23
DOBMEIER ERIC President, CEO President, CEO Apr 24 Option 0.42 25,000 10,500 326,138 04/26/23
Krishnan Mahesh Director Director Apr 01 Sell 23.01 924 21,261 1,275 04/04/23
DOBMEIER ERIC President, CEO President, CEO Jan 30 Sell 24.61 32,688 804,452 288,987 02/01/23
DOBMEIER ERIC President, CEO President, CEO Jan 30 Option 0.42 25,000 10,500 296,676 02/01/23
King Andrew James Chief Scientific Off.. Chief Scientific Officer Jan 03 Sell 25.82 10,000 258,200 9,992 01/04/23
King Andrew James Chief Scientific Off.. Chief Scientific Officer Jan 03 Option 0.35 7,500 2,625 19,992 01/04/23
King Andrew James Chief Scientific Off.. Chief Scientific Officer Aug 04 Option 0.35 5,000 1,750 10,897 08/05/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Aug 04 Sell 20 5,000 100,000 5,897 08/05/22
DOBMEIER ERIC President, CEO President, CEO May 25 Buy 13.0295 5,000 65,148 205,880 05/27/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Apr 11 Sell 15.36 5,000 76,800 5,897 04/13/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Apr 11 Option 0.35 5,000 1,750 10,897 04/13/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Feb 18 Sell 13.00 2,500 32,500 5,897 02/23/22
BJERKHOLT ERIC Chief Financial Offi.. Chief Financial Officer Feb 10 Sell 12.74 895 11,402 22,203 02/14/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Feb 10 Sell 12.74 2,498 31,825 8,397 02/14/22
Glicklich Alan Chief Medical Office.. Chief Medical Officer Feb 10 Sell 12.74 2,391 30,461 7,891 02/14/22
Frohlich Tom Chief Operating Offi.. Chief Operating Officer Feb 10 Sell 12.74 3,735 47,584 137,685 02/14/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Feb 10 Option 0.35 2,500 875 6,594 02/11/22
King Andrew James Chief Scientific Off.. Chief Scientific Officer Nov 09 Option 0.35 2,500 875 9,094 11/12/21
King Andrew James Chief Scientific Off.. Chief Scientific Officer Nov 09 Sell 13.53 5,000 67,650 4,094 11/12/21
Frohlich Tom Chief Operating Offi.. Chief Operating Officer Nov 05 Option 0.42 15,000 6,300 174,619 11/09/21
Frohlich Tom Chief Operating Offi.. Chief Operating Officer Nov 05 Sell 14.39 33,770 485,950 140,849 11/09/21
Jerel Davis Director Director Aug 31 Sell 14 850,000 11,900,000 644,149 08/31/21
Versant Venture Capital VII, L... 10% Owner 10% Owner Aug 31 Sell 14 850,000 11,900,000 644,149 08/31/21